Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
2020 Court Street Redding, CA 96001 Consent for MRI with Intravenous Contrast Your physician has referred you to our facility for a magnetic resonance examination. In certain cases, intravenous contrast solution using a Gadolinium based agent (Gadopentetate Dimeglumine, Gadobutrol or Gadofosveset Trisodium) is used to enhance the images and provide more information. This solution is injected into a vein and highlights the structures of interest and has been approved by the Food and Drug Administration as being safe and effective. If you have a history of diminished renal function or kidney disease, please inform the Technologist. As with all medications, occasional side effects and complications are possible. The injected contrast solution rarely causes headache, dizziness, nausea, vomiting, feeling hot or altered sense of taste. Some laboratory blood tests in patients with anemia or other blood diseases may be temporarily altered by this medication. The Technologist and/or Radiologist who performs your MRI examination will discuss this with you beforehand and will be glad to answer your questions. In particular, you should let them know if you are pregnant, breast feeding, if you have any anemia, or any other diseases that affect blood cells. I have read and understand the above statement and I give my consent to have MD Imaging perform this examination using intravenous contrast. I understand that in spite of every skill and prudent effort made to avoid complications during this procedure, there is no guarantee that a complication will not occur. Signature of Patient/Guardian: _________________________________________ Print Patient/Guardian Name: __________________________________________ Date: _____________________________________________________________ Revised 12/6/2013